| Potency, continence and complications in 3,477 consecutive radical retropubic prostatectomies SD Kundu, KA Roehl, SE Eggener, JAV Antenor, M Han, WJ Catalona The Journal of urology 172 (6 Part 1), 2227-2231, 2004 | 719 | 2004 |
| Tumor size is associated with malignant potential in renal cell carcinoma cases RH Thompson, JM Kurta, M Kaag, SK Tickoo, S Kundu, D Katz, ... The Journal of urology 181 (5), 2033-2036, 2009 | 333 | 2009 |
| Metastatic renal cell carcinoma risk according to tumor size RH Thompson, JR Hill, Y Babayev, A Cronin, M Kaag, S Kundu, ... The Journal of urology 182 (1), 41-45, 2009 | 255 | 2009 |
| Transforming growth factor‐β in benign and malignant prostate C Lee, SM Sintich, EP Mathews, AH Shah, SD Kundu, KT Perry, JS Cho, ... The prostate 39 (4), 285-290, 1999 | 225 | 1999 |
| NCCN Guidelines® insights: bladder cancer, version 2.2022: featured updates to the NCCN guidelines TW Flaig, PE Spiess, M Abern, N Agarwal, R Bangs, SA Boorjian, ... Journal of the National Comprehensive Cancer Network 20 (8), 866-878, 2022 | 204 | 2022 |
| Risk score and metastasectomy independently impact prognosis of patients with recurrent renal cell carcinoma SE Eggener, O Yossepowitch, S Kundu, RJ Motzer, P Russo The Journal of urology 180 (3), 873-878, 2008 | 192 | 2008 |
| The toll‐like receptor pathway: a novel mechanism of infection‐induced carcinogenesis of prostate epithelial cells SD Kundu, C Lee, BK Billips, GM Habermacher, Q Zhang, V Liu, LY Wong, ... The Prostate 68 (2), 223-229, 2008 | 174 | 2008 |
| Contemporary use of partial nephrectomy at a tertiary care center in the United States RH Thompson, M Kaag, A Vickers, S Kundu, M Bernstein, W Lowrance, ... The Journal of urology 181 (3), 993-997, 2009 | 173 | 2009 |
| Nuclear factor-κB-mediated transforming growth factor-β-induced expression of vimentin is an independent predictor of biochemical recurrence after radical prostatectomy Q Zhang, BT Helfand, TL Jang, LJ Zhu, L Chen, XJ Yang, J Kozlowski, ... Clinical cancer research 15 (10), 3557-3567, 2009 | 145 | 2009 |
| Prostate specific antigen density correlates with features of prostate cancer aggressiveness SD Kundu, KA Roehl, X Yu, JAV Antenor, BK Suarez, WJ Catalona The Journal of urology 177 (2), 505-509, 2007 | 145 | 2007 |
| Suppression of tumor metastasis by blockade of transforming growth factor β signaling in bone marrow cells through a retroviral-mediated gene therapy in mice AH Shah, WB Tabayoyong, SD Kundu, SJ Kim, L Van Parijs, VC Liu, ... Cancer research 62 (24), 7135-7138, 2002 | 97 | 2002 |
| Incidence and outcomes of ductal carcinoma of the prostate in the USA: analysis of data from the Surveillance, Epidemiology, and End Results program JJ Meeks, LC Zhao, J Cashy, S Kundu BJU international 109 (6), 831-834, 2012 | 89 | 2012 |
| Diagnostic value of guided biopsies: fusion and cognitive-registration magnetic resonance imaging versus conventional ultrasound biopsy of the prostate DT Oberlin, DD Casalino, FH Miller, RS Matulewicz, KT Perry, RB Nadler, ... Urology 92, 75-79, 2016 | 78 | 2016 |
| Preoperative PSA and progression-free survival after radical prostatectomy for Stage T1c disease JAV Antenor, KA Roehl, SE Eggener, SD Kundu, M Han, WJ Catalona Urology 66 (1), 156-160, 2005 | 78 | 2005 |
| Predictors of readmission following outpatient urological surgery A Rambachan, RS Matulewicz, M Pilecki, JYS Kim, SD Kundu The Journal of urology 192 (1), 183-188, 2014 | 72 | 2014 |
| Inflammatory bowel disease and the risk of prostate cancer JA Burns, AB Weiner, WJ Catalona, EV Li, EM Schaeffer, SB Hanauer, ... European urology 75 (5), 846-852, 2019 | 70 | 2019 |
| Blockade of transforming growth factor-β signaling in tumor-reactive CD8+ T cells activates the antitumor immune response cycle Q Zhang, XJ Yang, SD Kundu, M Pins, B Javonovic, R Meyer, SJ Kim, ... Molecular cancer therapeutics 5 (7), 1733-1743, 2006 | 69 | 2006 |
| Improved stage and grade-specific progression-free survival rates after radical prostatectomy in the PSA era NV Desireddi, KA Roehl, S Loeb, X Yu, CR Griffin, SK Kundu, M Han, ... Urology 70 (5), 950-955, 2007 | 66 | 2007 |
| Down-regulation of TGF-β 1 production restores immunogenicity in prostate cancer cells E Matthews, T Yang, L Janulis, S Goodwin, SD Kundu, WJ Karpus, C Lee British journal of cancer 83 (4), 519-525, 2000 | 66 | 2000 |
| Empiric antibiotics for an elevated prostate‐specific antigen (PSA) level: a randomised, prospective, controlled multi‐institutional trial SE Eggener, MC Large, GS Gerber, J Pettus, O Yossepowitch, ND Smith, ... BJU international 112 (7), 925-929, 2013 | 62 | 2013 |
